Finding variants of uncertain significance does not increase the rate of contralateral prophylactic mastectomies
Links between bacterial composition and breast cancer
Carrying the gene confers the same fears as a diagnosis
Extends the benefits of NSM to more patients and improves outcomes
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
What to look for and when to screen
A recent clinical trial tested neoadjuvant therapies
Safe, effective, welcome option
Neratinib and trastuzumab emtansine (T-DM1) combination potent and well tolerated
Clinical trials testing olaparib in breast cancer
Advertisement
Advertisement